Technology Offers New Hope as a Brain Tumor Treatment

The NovoTTF-100A System uses electrodes to treat glioblastoma multiforme (GBM), the most aggressive form of brain tumor.

In 2010, there were 13,140 deaths from brain and other nervous system cancers in the United States. In April 2011, the FDA approved the NovoTTF-100A System that will offer new hope for adults with recurring or progressing GBM even after receiving chemotherapy and radiation therapies.

FDA Approves New Melanoma Treatment

Yervoy, a drug found to prolong the lives of melanoma patients, is approved by the FDA.

"There were about 68,000 new cases of melanoma in the United States last year and 8,700 deaths, according to the American Cancer Society. The number of cases has been rising, probably because of sun exposure without proper protection at a younger age."